2 Groups model FDA [Two-Stage / GS Designs]

posted by hiren379 – India, 2013-08-22 16:32 (4248 d 22:57 ago) – Posting: # 11336
Views: 44,349

Hi HS

❝ Followed by:

❝ If the Group-by-treatment interaction test is not statistically significant (p ≥0.1), only the Group-by-treatment term can be dropped from the model.

❝ … provided that the group meets minimum requirements for a complete bioequivalence study.


According to the above statement, what should be the minimum requirements of the group for a complete bioequivalence study?

Complete thread:

UA Flag
Activity
 Admin contact
23,422 posts in 4,927 threads, 1,667 registered users;
39 visitors (0 registered, 39 guests [including 11 identified bots]).
Forum time: 15:29 CEST (Europe/Vienna)

To know the history of science is to recognize the mortality
of any claim to universal truth.    Evelyn Fox Keller

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5